1. Anonymus. Guidelines for the determination of death: Report of the medical consultants on the diagnosis of death to the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. JAMA 246 (1981) 2184–2186
2. Büll U, Krappel W, Schmiedek P, et al: I-123 Amphetamine vs. Xe-133 SPECT. A Comparative Study in Patients with Unilateral Cerebro-vascular Disease (CVD). J Nucl Med 26 (1985) P25
3. Costa DC, Ell PJ, Cullum ID, et al: The in vivo distribution of99Tcm-HM-PAO in normal man. Nucl Med Commun 7 (1986) 647–658
4. Creutzig H, Schober O, Gielow, P, et al: Cerebral Dynamics of N-Isopropyl-(123I)p-Iodoamphetamine. J Nucl Med 27 (1986) 178–183
5. Galaske RG, Schober O, Heyer R:99mTc-HM-PAO and123I-Amphetamine cerebral scintigraphy: a new, non invasive method in determination of brain death in children. In preparation